Vol. 5 No. 1.5 (2012): August

Vol. 5 No. 1.5 (2012)

Published November 12, 2023
August

Original Research Article

JN Goldstein, HB Brouwers, JM Romero, K McNamara, K Schwab, SM Greenberg, J Rosand
SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study
https://doi.org/10.5281/zenodo.10349550 PDF
NA McBee, DF Hanley, CS Kase, K Lane, JR Carhuapoma
The importance of an independent oversight committee to preserve treatment fidelity, ensure protocol compliance, and adjudicate safety endpoints in the ATACH II trial
https://doi.org/10.5281/zenodo.10349427 PDF
K Toyoda, S Sato, M Koga, H Yamamoto, J Nakagawara, E Furui, Y Shiokawa, Y Hasegawa, S Okuda, N Sakai, K Kimura, Y Okada, S Yoshimura, H Hoshino, Y Uesaka, T Nakashima, Y Itoh, T Ueda, T Nishi, J Gotoh, K Nagatsuka, S Arihiro, T Yamaguchi, K Minematsu
Run-up to participation in ATACH II in Japan
https://doi.org/10.5281/zenodo.10349303 PDF
AI Qureshi, B Connelly, EI Abbott, E Maland, J Kim, J Blake
Mobile applications for handheld devices to screen and randomize acute stroke patients in clinical trials
https://doi.org/10.5281/zenodo.10349584 PDF
J Roberts, S Waddy, P Kaufmann
Recruitment and retention monitoring: facilitating the mission of the National Institute of Neurological Disorders and Stroke (NINDS)
https://doi.org/10.5281/zenodo.10349461 PDF
AI Qureshi, YY Palesch, ATACH II Investigators
Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial
https://doi.org/10.5281/zenodo.10349388 PDF